Results for tag: "Pegvisomant"

Pegvisomant is a drug used to treat endocrine and metabolic disorders. It is a recombinant form of human growth hormone, and is used to treat acromegaly, a condition caused by excessive growth hormone production. Pegvisomant works by blocking the action of growth hormone, thereby reducing the symptoms of acromegaly. It is administered as a subcutaneous injection, and is typically taken once a day. Pegvisomant is a relatively new drug, and is still in the early stages of development. It is currently approved for use in the United States, Europe, and other countries. The drug is marketed by several pharmaceutical companies, including Pfizer, Novartis, and Ipsen. Pegvisomant is a promising treatment for endocrine and metabolic disorders, and is expected to become increasingly popular in the coming years. It is a safe and effective treatment for acromegaly, and is well-tolerated by patients. Show Less Read more